BioNTech (ADRs) Aktie
88,35
EUR
+1,65
EUR
+1,90
%
98,00
USD
+0,42
USD
+0,43
%
Werbung
BioNTech (ADRs) Aktie Analyse
| 24.09.21 | BioNTech (ADRs) Neutral | Goldman Sachs Group Inc. | |
| 23.09.21 | BioNTech (ADRs) Neutral | Goldman Sachs Group Inc. | |
| 23.09.21 | BioNTech (ADRs) Neutral | UBS AG | |
| 11.08.21 | BioNTech (ADRs) Neutral | Goldman Sachs Group Inc. | |
| 10.08.21 | BioNTech (ADRs) Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.05.21 | BioNTech (ADRs) Neutral | Goldman Sachs Group Inc. | |
| 31.03.21 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
| 31.03.21 | BioNTech (ADRs) buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
|
Werbung
|
|||
| 11.01.21 | BioNTech (ADRs) buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.11.20 | BioNTech (ADRs) buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.11.20 | BioNTech (ADRs) buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.11.20 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
| 22.09.20 | BioNTech (ADRs) buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
Werbung
Werbung